LINC02466 promotes the progression of hepatocellular carcinoma through the mTOR pathway
LINC02466 regulating cell proliferation, the cell cycle, and stemness characteristics via the mTOR pathway, suggesting LINC02466 as a potential therapeutic target for primary liver cancer.
Authors
- Xuebin Qin (ORCID: https://orcid.org/0000-0001-9875-983X)
- Zhipeng Quan (ORCID: https://orcid.org/0000-0002-1079-5666)
- Hao Yan (ORCID: https://orcid.org/0000-0003-1468-6165)
- Bo Tang (ORCID: https://orcid.org/0000-0003-4089-5155)
- Zhenran Wang
- Jiaming Liang (ORCID: https://orcid.org/0000-0002-9878-3554)
- Fuqiang Wang (ORCID: https://orcid.org/0000-0002-5500-9649)
- Shiqian Liu
Institutions
- Guangxi Medical University (CN)
- Guilin Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1007/s12672-024-00999-x
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Guangxi Province
- Guangxi Medical University